October 2011
Br J Cardiol 2011;18:219–22
Patent foramen ovale: diagnosis, indications for closure and complications
The purpose of this review is to give a broad overview of the role of patent foramen ovale (PFO) in disease. The embryological origins of...
Read More
October 2011
Br J Cardiol 2011;18:224-228
Drugs for diabetes: part 7 insulin
Insulin remains an important treatment for patients with type 1 and type 2 diabetes. Insulin is given to patients with type 1 diabetes as a...
Read More
October 2011
Br J Cardiol 2011;18:231–2
Multi-disciplinary valve clinics with devolved surveillance: a two-year audit
Sonographer- and nurse-led clinics were developed at a cardiothoracic centre and a sonographer-led clinic at a district general hospital (DGH). Common database fields were adopted...
Read More
October 2011
Br J Cardiol 2011;18:233-237
Alcohol septal ablation in hypertrophic obstructive cardiomyopathy
Alcohol septal ablation (ASA) is an alternative therapeutic method to the gold-standard surgical myectomy in the treatment of symptomatic left ventricular outflow tract (LVOT) obstruction...
Read More
October 2011
Br J Cardiol 2011;18:238-240
Aspirin taking in a south Wales county
In order to determine the taking of regular aspirin within a representative community sample of adults residing in the south Wales county of Caerphilly, we...
Read More
October 2011
Br J Cardiol 2011;18:246-248
Recurrent stent thrombosis with dual antiplatelet resistance: the role of platelet function testing
Platelet activation is an important part of the pathophysiology of acute coronary syndromes. Inhibition of this by antiplatelet agents forms an important part of the...
Read More
October 2011
Br J Cardiol 2011;18:241-242
Mitral valve leaflet and free-floating left atrial thrombi with ‘rhupus’ and antiphospholipid syndrome
A 27-year-old Arab woman with history of seronegative rheumatoid arthritis for four years presented with a three-day history of multiple joint pains and swelling, along with...
Read More
October 2011
Br J Cardiol 2011;18:243-245
Cabergoline as an adjunct for early left ventricular recovery in peripartum cardiomyopathy
Outcome in patients with peripartum cardiomyopathy (PPCM) is variable. Recovery of left ventricular function is observed in between 23% and 51% of cases at six...
Read More
August 2011
Br J Cardiol 2011;18:167–69
Drugs for diabetes: part 6 GLP-1 receptor agonists
The glucagon-like peptide-1 (GLP-1) receptor agonists are a new class of injected drugs for the treatment of type 2 diabetes. They mimic the action of...
Read More
August 2011
Br J Cardiol 2011;18:171–76
MyAction: an innovative approach to the prevention of cardiovascular disease in the community
We developed and piloted an innovative family-centred preventive cardiology programme (MyAction) that aimed to both integrate the care of patients with vascular disease with that...
Read More